• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Dx Deals: Abbott Closes Exact Sciences Acquisition, Takes Control of Cologuard Franchise

Dx Deals: Abbott Closes Exact Sciences Acquisition, Takes Control of Cologuard Franchise

by Ron Shinkman | Apr 14, 2026 | Deals-lir, Essential, Lab Industry Advisor

Biotech giant purchased the company for $21 billion, one of the largest deals in clinical lab history

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Labcorp Buys Select Assets of Empire City Laboratories

Dx Deals: Labcorp Buys Select Assets of Empire City Laboratories

by Ron Shinkman | Mar 25, 2026 | Deals-lir, Essential, Lab Industry Advisor

The national lab giant swiftly merged Empire City’s operations into its own

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Fulgent Genetics Scores Two Laboratories in a Single Deal

Dx Deals: Fulgent Genetics Scores Two Laboratories in a Single Deal

by Ron Shinkman | Feb 23, 2026 | Deals-lir, Essential, Lab Industry Advisor

It is acquiring Bako Diagnostics and StrataDx for a combined $55.5 million

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Seeking Expanded MRD Testing, Natera Acquires Foresight Diagnostics in $450M Deal

Dx Deals: Seeking Expanded MRD Testing, Natera Acquires Foresight Diagnostics in $450M Deal

by Ron Shinkman | Jan 26, 2026 | Deals-lir, Essential, Lab Industry Advisor

Agreement is part of the Natera’s aggressive growth model as it strives to turn a profit

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Dx Deals: Labcorp and BioReference Health Agree on $225m Sale of Some Assets

Dx Deals: Labcorp and BioReference Health Agree on $225m Sale of Some Assets

by Ron Shinkman | Jun 19, 2025 | Deals-lir, Essential, Lab Industry Advisor

Labcorp will acquire oncology-related clinical tests services from BioReference’s parent company, OPKO Health

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2026 G2Intelligence.com